Success Story: Without RFE, A Senior Research Associate from China gained EB1A Approval in Just Over 3 Months

Client’s Testimonial:

“Thank you for the good news and for your help throughout my application process!”

On November 17^th, 2025, we received another EB-1A (Alien of Extraordinary Ability) approval for a Senior Research Associate in the Field of Biotechnology (Approval Notice).

General Field: Biotechnology

Position at the Time of Case Filing: Senior Research Associate

Country of Origin: China

State of Residence at the Time of Filing: North Carolina

Approval Notice Date: November 17^th, 2025

Processing Time: 3 months, 3 days

Case Overview:

Our firm successfully secured EB-1A approval for a senior research associate from China in the field of biotechnology. The petition was approved in just over 3 months without a Request for Evidence.

Academic Qualifications and Professional Standing:

The beneficiary holds a Ph.D. in Biochemistry. At the time of filing, the client was conducting research in protein engineering, therapeutic development, and cellular disease mechanisms. The proposed endeavor involves continuing advanced biotechnology research with applications in diagnostic tools and therapeutic strategies addressing critical healthcare priorities.

Research Impact and Recognition:

The client’s scholarly contributions comprise 14 peer-reviewed journal articles (7 first- or co-first-authored) and 4 peer-reviewed conference articles (1 first-authored). This body of work has generated 224 citations, demonstrating widespread adoption and influence within the international scientific community. Research activities have been supported by the National Institutes of Health (NIH).

The client has performed at least 16 peer reviews for distinguished journals in biotechnology and related disciplines, evidencing recognition as an expert evaluator by leading academic publishers.

National Interest and Expert Testimony:

The petition demonstrated that the client’s research advances United States leadership in biotechnology and aligns with federal health research priorities. The work addresses national needs in precision medicine and translational research, with direct applications to disease understanding and therapeutic development.

Four expert recommendation letters from internationally recognized authorities provided independent validation of the client’s contributions. One expert stated:

“[The Client] has a unique aptitude for ingenuity in the field of biotechnologies. I fully endorse the extension of his outstanding research here in the United States.”

Conclusion:

Drawing on our extensive experience and a proven track record of over 32,000 successful cases, our expert team meticulously prepared a petition demonstrating that the beneficiary has achieved sustained national and international acclaim in biotechnology. USCIS’s approval confirms the client’s extraordinary ability and standing among the top echelon of researchers in the field. We are honored to have supported this accomplished scientist and extend our sincere best wishes for his continued contributions to advancing biotechnology innovation and healthcare solutions in the United States.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.